Lee J. Discovery of Aspergillus as a human pathogen. http://www.antimicrobe.org/hisphoto/history/Aspergillus-Human%20Pathogen.pdf, 2023.
2. Arastehfar A, Carvalho A, Houbraken J et al. Aspergillus fumigatus and aspergillosis: From basics to clinics. Stud Mycol. 2021; 100:100115.
3. Patterson TF. Treatment and prevention of invasive aspergillosis. https://www.uptodate.com/contents/treatment-and-prevention-of-invasive-aspergillosis, 2022.
4. Douglas AP, Smibert OC, Bajel A, Halliday CL, et al. Consensus guidelines for the diagnosis and management of invasive aspergillosis. Intern Med J. 2021; 51 Suppl 7:143-176.
5. Dobiáš R, Stevens DA, Havlíček V. Current and Future Pathways in Aspergillus Diagnosis. Antibiotics (Basel). 2023; 12:385.
6. Westblade LF, Burd EM , Lockhart SR, Procop GW with Larone DH ,Walsh TJ, eds.Larone’s Medically Important Fungi: A Guide to Identification .7th edition.Washington DC, ASM Press;
2023.
7. Houbraken J., Kocsubé S., Visagie C.M. Classification of Aspergillus, Penicillium, Talaromyces and related genera (Eurotiales): An overview of families, genera, subgenera, sections, series and
species. Studies in Mycology. 2020; 95:5–169.
8. Bhargawa B. Standard operating procedures for Fungal identification and detection of antifungal resistance, Antimicrobial resistance and surveillance research network.2nd edition, New
Delhi, Royal Offset; 2019.
9. Latgé JP, Chamilos G. Aspergillus fumigatus and aspergillosis in 2019. Clin Microbiol Rev. 2019; 33:e00140-18.
10. Patterson TP, Thompson GR, Denning DW, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin Infect
Dis 2016; 63:e1–e60.
11. Kanaujia R, Singh S, Rudramurthy SM. Aspergillosis: an Update on Clinical Spectrum, Diagnostic Schemes, and Management. Curr Fungal Infect Rep. 2023; 4:1-12.
12. Rudramurthy SM, Paul RA, Chakrabarti A, Mouton JW, Meis JF. Invasive Aspergillosis by Aspergillus flavus: Epidemiology, Diagnosis, Antifungal Resistance, and Management. J Fungi
(Basel). 2019; 5:55.
13. Risslegger B, Zoran T, Lackner M, et al. A prospective international Aspergillus terreus survey: an EFISG, ISHAM and ECMM joint study. Clin Microbiol Infect. 2017; 23:776.e1-776.e5.
14. Cadena J, Thompson GR 3rd, Patterson TF. Aspergillosis: Epidemiology, Diagnosis, and Treatment. Infect Dis Clin North Am. 2021;35:415-434.
15. Schauwvlieghe AFAD, Rijnders BJA, Philips N et al.Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med.
2018 Oct;6(10):782-792.
16. Schwartz IS, Friedman DZP, Zapernick L, et al. High Rates of Influenza-Associated Invasive Pulmonary Aspergillosis May Not Be Universal: A Retrospective Cohort Study from Alberta,
Canada. Clin Infect Dis. 2020; 71:1760-1763.
17. Chong WH, K P Neu. Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review. J Hosp Infect. 2021; 113:115-129.
18. Er B, Er AG, Gülmez D et al. A screening study for COVID-19-associated pulmonary aspergillosis in critically ill patients during the third wave of the pandemic. Mycoses 2022;65:724-732.
19. Earle K, Valero C, Conn DP et al. Pathogenicity and virulence of Aspergillus fumigatus. Virulence 2023;14:2172264.
20. Thompson GR 3rd, Young JH. Aspergillus Infections. N Engl J Med. 2021;385:1496-1509.
21. Bavadharani S, Premamalini T, Karthika K, Kindo AJ. In Vitro Production of Virulence Factors and Antifungal Susceptibility Pattern of Aspergillus Isolates from Clinical Samples in a Tertiary
Care Center. J Lab Physicians. 2022;14(4):479-484.
22. Patin EC, Thompson A, Orr SJ. Pattern recognition receptors in fungal immunity. Semin Cell Dev Biol. 2019; 89:24-33.
23. Vuong MF. Aspergillosis. https://www.scribd.com/document/503499241/Aspergillosis-StatPearls-NCBI-Bookshelf 2023.
24. Lass-Flörl C, Dietl AM, Kontoyiannis DP, Brock M. Aspergillus terreus Species Complex. Clin Microbiol Rev. 2021; 34:e0031120.
25. J. Peter Donnelly, Chen SC, Kauffma CA, et al. Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of
Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis 2020; 71:1367–76.
26. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international
consensus. Clin Infect Dis. 2002; 34:7–14.
27. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections
Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008; 46:1813-21.
28. Koehler P, Bassetti M, Chakrabarti A, et al. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical
guidance. Lancet Infect Dis. 2021; 21:e149-e162.
29. Ullmann AJ, Aguado JM, Arikan-Akdagli S, et al. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin Microbiol Infect
2018; Suppl 1:e1-e38.
30. Aerts R, Feys S, Mercier T, Lagrou K. Microbiological Diagnosis of Pulmonary Aspergillus Infections. Semin Respir Crit Care Med. 2024; 45:21-31.
31. Aerts R, Cuypers L, Mercier T, Maertens J, Lagrou K. Implementation of Lateral Flow Assays for the Diagnosis of Invasive Aspergillosis in European Hospitals: A Survey from Belgium and a
Literature Review of Test Performances in Different Patient Populations. Mycopathologia. 2023; 188:655-665.
32. Liu WD, Lin SW, Shih MC False-positive Aspergillus galactomannan immunoassays associated with intravenous human immunoglobulin administration. Clin Microbiol Infect. 2020;
26:1555.e9-1555.e14.
33. Jenks JD, Miceli MH, Prattes J, Mercier T, Hoenigl M. The Aspergillus Lateral Flow Assay for the Diagnosis of Invasive Aspergillosis: an Update. Curr Fungal Infect Rep. 2020 Dec 4:1-6.
34. Heldt S, Hoenigl M. Lateral Flow Assays for the Diagnosis of Invasive Aspergillosis: Current Status. Curr Fungal Infect Rep. 2017; 11:45-51.
35. Alhan O, Saba R, Akalin EH et al. Diagnostic Efficacy of Aspergillus Galactomannan Lateral Flow Assay in Patients with Hematological Malignancies: A Prospective Multicenter Study.Myco-
pathologia. 2023; 188:643-653.
36. Hammarström H, Stjärne Aspelund A, Christensson B, et al. Prospective evaluation of a combination of fungal biomarkers for the diagnosis of invasive fungal disease in high-risk haemato-
logy patients. Mycoses. 2018; 61:623-632.
37. Dobias R, Jaworska P, Tomaskova H, et al. Diagnostic value of serum galactomannan, (1,3)-beta-d-glucan, and Aspergillus fumigatus-specific IgA and IgG assays for invasive pulmonary
aspergillosis in non-neutropenic patients. Mycoses. 2018; 61:576-586.
38. Weinbergerova B, Kabut T, Kocmanova I, et al. Bronchoalveolar lavage fluid and serum 1,3-β-D-glucan testing for invasive pulmonary aspergillosis diagnosis in hematological patients: the
role of factors affecting assay performance. Sci Rep. 2020; 10:17963.
39. Warris A, Lehrnbecher T, Roilides E et al. ESCMID-ECMM guideline: diagnosis and management of invasive aspergillosis in neonates and children. Clin Microbiol Infect. 2019; 25:1096-1113.
40. Blot SI, Taccone FS, Van den Abeele AM et al. A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients. Am J Respir Crit Care Med. 2012; 186:56-64.
41. Hamam J, Navellou JC, Bellanger AP et al.New clinical algorithm including fungal biomarkers to better diagnose probable invasive pulmonary aspergillosis in ICU. Ann Intensive Care. 2021;
11:41.
42. Verweij PE , Rijnders BJA, Brüggemann RJM et al. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion. Intensive Care
Med 2020; 46:1524-1535.
43. Tissot F, Agrawal S, Pagano L, et al. ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients.
Haematologica. 2017; 102:433-444.
44. Verweij PE, Brüggemann RJM, Azoulay E et al. Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis. Intensive Care Med. 2021;
47:819-834.
45. Boyer J, Feys S, Zsifkovits I, Hoenigl M, Egger M. Treatment of Invasive Aspergillosis: How It’s Going, Where It’s Heading. Mycopathologia. 2023; 188:667-681.
46. Ener B, Ergin Ç, Gülmez D, Ağca H, et al. Frequency of azole resistance in clinical and environmental strains of Aspergillus fumigatus in Turkey: a multicentre study. J Antimicrob Chemother.
2022; 77:1894-1898